Related references
Note: Only part of the references are listed.Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome A MAGNIMS Study
Massimo Filippi et al.
NEUROLOGY (2022)
A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes
Karen K. Chung et al.
ANNALS OF NEUROLOGY (2020)
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
Ludwig Kappos et al.
NEUROLOGY (2016)
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
Giancarlo Comi et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
G. Comi et al.
LANCET (2009)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
